Inventor · disambiguated record
Yaling Wang
Also filed as: WANG YALING
11 granted patents·14 pending applications·59 citations·filing 2000–2024
87Inventor score
Files withMERCK & CO INC5GUANGZHOU REALBENEFITSPOT PHARMACEUTICAL CO LTD4SHANGHAI CELGEN BIO PHARMACEUTICAL CO LTD4BEIJING SANYUAN FOODS CO LTD2CAMPOS KEVIN R1
Top patents by PatentIndex Score
25 records- 0191US10865404B1Aspartase mutant, recombinant expression vector and recombinant bacterium containing aspartase mutant, and use thereofUNIV JIANGNAN·Filed 2020·Granted Dec 15, 2020·6 cites·7 claims
- 0288US7629470B2Formation of tetra-substituted enamides and stereoselective reduction thereofMERCK & CO INC·Filed 2005·Granted Dec 8, 2009·11 cites·10 claims
- 0385US6407241B1Process and intermediates for the preparation of imidazolidinone αv integrin antagonistsMERCK & CO INC·Filed 2000·Granted Jun 18, 2002·19 cites·13 claims
- 0476US8637449B2Processes for preparing protease inhibitors of hepatitis C virusSONG ZHIGUO JAKE·Filed 2010·Granted Jan 28, 2014·8 cites·26 claims
- 0576US7074930B2Amine salts of an integrin receptor antagonistMERCK & CO INC·Filed 2002·Granted Jul 11, 2006·10 cites·28 claims
- 0676US2025333507A1Fusion protein of anti-tigit antibody and il2 or variant thereof, and application thereofSHANGHAI CELGEN BIO PHARMACEUTICAL CO LTD·Filed 2023·Application pending·0 cites
- 0771US6509347B2Crystalline forms of an integrin receptor antagonistMERCK & CO INC·Filed 2002·Granted Jan 21, 2003·5 cites·19 claims
- 0871US2024400680A1Fusion protein of anti-tigit antibody and il2 or variant thereof and application thereofSHANGHAI CELGEN BIO PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 0971US2024417462A1Monoclonal antibody targeting tigitSHANGHAI CELGEN BIO PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 1063US12465634B2Use of trimanganese tetraoxide particles in preparation of vaccine adjuvantGUANGZHOU REALBENEFITSPOT PHARMACEUTICAL CO LTD·Filed 2024·Granted Nov 11, 2025·0 cites·21 claims
- 1160US2025152700A1Aluminum nanocrystal delivery system, and self-assembled particle adjuvant vaccine based on binding of aluminum nanocrystal delivery system and vaccine antigen moleculeGUANGZHOU REALBENEFITSPOT PHARMACEUTICAL CO LTD·Filed 2023·Application pending·0 cites
- 1259US2024392024A1Anti-tnfr2 monoclonal antibody and application thereofSHANGHAI CELGEN BIO PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 1357US2024264179A1Marker set for evaluating the development of infant’s communication ability and use thereofBEIJING SANYUAN FOODS CO LTD·Filed 2023·Application pending·0 cites
- 1457US2024345098A1Method for multidimensional evaluation of the similarity of samples to breast milkBEIJING SANYUAN FOODS CO LTD·Filed 2023·Application pending·0 cites
- 1556US2025161480A1Aluminum nanocrystalline composite immune drug and preparation method therefor and use thereofGUANGZHOU REALBENEFITSPOT PHARMACEUTICAL CO LTD·Filed 2023·Application pending·0 cites
- 1656US2025161226A1Aluminum-based self-assembled delivery system for mrna, method for preparing same, and use thereofGUANGZHOU REALBENEFITSPOT PHARMACEUTICAL CO LTD·Filed 2023·Application pending·0 cites
- 1755US2010041893A1Formation of tetra-substituted enamides and stereoselective reduction thereofCAMPOS KEVIN R·Filed 2009·Application pending·0 cites
- 1853US7893081B2Tyrosine kinase inhibitorsMERCK & CO INC·Filed 2008·Granted Feb 22, 2011·0 cites·2 claims
- 1951US8507504B2Process for producing bicycloaniline derivativesFURUKAWA SHUNTARO·Filed 2009·Granted Aug 13, 2013·0 cites·10 claims
- 2051US2025152622A1Aluminum-manganese composite nanocrystal, and preparation method therefor and use thereofTHE GBA NAT INSTITUTE FOR NANOTECHNOLOGY INNOVATION·Filed 2022·Application pending·0 cites
- 2145US7700611B2Synthesis and crystalline forms of NPY5 antagonistMERCK SHARP & DOHME·Filed 2006·Granted Apr 20, 2010·0 cites·19 claims
- 2244US10526611B2Gene targeting using mutant Agrobacterium strainsGELVIN STANTON B·Filed 2015·Granted Jan 7, 2020·0 cites·8 claims
- 2342US2005113577A1Solid forms of slats with tyrosine kinase activityFiled 2003·Application pending·0 cites
- 2439US2008227786A1Novel Crystalline Salts of a Dipeptidyl Peptidase-IV InhibitorFERLITA RUSSELL R·Filed 2005·Application pending·0 cites
- 2536US2003125336A1Hydrohalide salts of an HIV protease inhibitorFiled 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Yaling Wang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →